Correlation of Macular Thickness and Visual Acuity in DME Treated by Two Doses of Intravitreal Ziv-Aflibercept Versus Bevacizumab Analysis of a Randomized, Three-Armed Clinical Trial

Correlation of Macular Thickness and Visual Acuity in DME Treated by Two Doses of Intravitreal Ziv-Aflibercept Versus Bevacizumab : Analysis of a Randomized, Three-Armed Clinical Trial

Copyright 2019, SLACK Incorporated.

Détails bibliographiques
Publié dans:Ophthalmic surgery, lasers & imaging retina. - 2013. - 50(2019), 11 vom: 01. Nov., Seite 684-690
Auteur principal: Jabbarpoor Bonyadi, Mohammad Hossein (Auteur)
Autres auteurs: Baghi, Ahmadreza, Ramezani, Alireza, Yaseri, Mehdi, Soheilian, Masoud
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Ophthalmic surgery, lasers & imaging retina
Sujets:Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Angiogenesis Inhibitors Recombinant Fusion Proteins aflibercept 15C2VL427D Bevacizumab 2S9ZZM9Q9V Receptors, Vascular Endothelial Growth Factor EC 2.7.10.1
Accès en ligne Volltext